cardio peripher vascular case count treatment set
trend appear acceler
semi compon distributor semi cyclepath
et conf call kol leader discuss commerci
potenti eravacyclin ciai nash
kol call today et discuss commerci
potenti eravacyclin ciai
dial
valid
strh biotech team host investor call key
opinion leader discuss commerci potenti eravacyclin
complic intra-abdomin infect ciai tetraphas
announc posit top-lin result
nda eravacyclin ciai
review ema fda respect pdufa date
august believ call valu add investor
address follow
current treatment paradigm ciai
import factor drive uptak antibiot treat ciai
commerci potenti eravacyclin ciai base data
phase studi
andrew shorr md mph section director pulmonari
critic medicin director medic icu medstar
washington hospit center washington addit dr
shorr associ professor medicin georgetown univers
washington dr shorr receiv medic degre
univers virginia complet mph polici
ethic john hopkin univers school hygien public
baltimor complet resid intern medicin
walter reed armi medic center washington
fellowship pulmonari critic medicin also walter
infect caus multi-drug
compani lead product candid eravacyclin fulli synthet
fluocyclin strong potenc broad spectrum gram-
posit gram-neg atyp anaerob bacteria
tetraphas announc posit top-lin result
ciai
treatment seriou
develop novel
inc buy confid
improv busi model swell take pt buy
improv busi model host investor meet
ceo tom edman develop greater confid
compani improv busi model includ abil
grow sale expand margin achiev ep
consensu highlight recent
analyst day note increas confid factor might
trigger transit valuat methodolog blend
ev/ebitda price-to-earnings straight price-to-earnings basi confid
swell increas pt base still
bullish follow upbeat analyst day focus
across multipl product increasingli differenti it/
digit capabl medicaid exchang continu hum
expect on-going expans footprint view global
 correct potenti appreci opportun
addit think assets/invest provid attract
cost/car manag tool fide deal provid
nice tailwind reiter buy rais pt
bring opportun diversifi
nation footprint home florida market still repres fifth
revenu import exposur construct coastal
properti heavi renew analysi
recent data point indic fundament backdrop solid
though florida properti may modest net impact
organ growth least improv drag prior
quarter attract cash yield group along
improv prospect organ growth margin
reiter buy rate price target mark hugh
pt reflect bh acquisit tweak
estim reflect recent announc boat
hold acquisit adjust non-cash amort
charg previou acquisit also rais pt
vs maintain hold rate michael
fire water boil order impact updat
estim account oper impact fire one
compani egg facil water boil order anoth
result incid lower ebitda
estim full-year ebitda estim
amount financi impact
page
event expect insur take
conserv approach reimburs
factor estim ebitda estim
unchang price target ebitda in-lin
peer william chappel jr
electr power util
electr power util power/util macro trend
analysi key macro factor impact power/util
sector includ forward price spark spread dark spread
nation weather pattern edit weekli
report introduc forward commod price
analysi base latest peer group valuat
chang price target
 ali agha
weekli sector comparison compani includ
 neal dingmann well fitzpatrick
bring opportun diversifi
nation footprint home florida market still repres fifth
revenu import exposur construct coastal
properti heavi renew analysi
recent data point indic fundament backdrop solid
though florida properti may modest net impact
organ growth least improv drag prior
quarter attract cash yield group along
improv prospect organ growth margin
reiter buy rate price target mark hugh
investor day takeaway reinvest growth rais
pt attend compass diversifi hold annual
investor day nyc came away increas confid
manag effect deploy capit fuel growth
platform increas gap cad
dividend believ codi benefit recent accret
acquisit tax reform continu lay foundat
acceler cad/shar growth capac
addit tuck-in acquisit pt equat
page
bv premium peer reflect strong earn
growth prospect sotp valu dougla mewhirt
 client asset track estim
reiter buy rate follow schwab monthli weekli
metric report featur moder dart growth
expect record level improv client asset growth
anticip slightli lower expect interest-
earn asset ep estim
unchang could potenti prove bit
conserv maintain pt equal
ep assum stock trade back averag
price-to-earnings continu believ compani best strateg
posit retail broker dougla mewhirt
bullish follow upbeat analyst day focus
across multipl product increasingli differenti it/
digit capabl medicaid exchang continu hum
expect on-going expans footprint view global
 correct potenti appreci opportun
addit think assets/invest provid attract
cost/car manag tool fide deal provid
nice tailwind reiter buy rais pt
surviv tick longer follow
still encourag eha bellicum present data
genet modifi stem cell transplant pediatr
patient aml primari immun disord pid aml
data remain encourag median follow-up day
rf os patient
respect pid data also encourag
median follow-up day os
essenti in-line abstract
overal believ updat keep us posit
bellicum posit reiter buy pt peter
cardio use fee servic ff state nation
inpati sampl data arriv all-pay case count estim
endovascular peripher vascular intervent
estim case show compound-annual-growth-rate
estim atherectomi stent
case atherectomi stent
case growth slow toward end
period strong growth atherectomi offic
base treatment like influenc reimbursement/profit
page
secur nsclc approv china provinci price
announc updat data keytruda trial r/
 hodgkin lymphoma show orr constant
patient cr rate tick
announc amend
current trial allow pretreat patient enrol plan
begin discuss registr trial post r/r hl
lymphoma regulatori author later year
remain bullish affim nk cell redirect technolog
encourag develop regulatori path reiter buy
appeal orr tick possibl wildtyp
 provid updat tazemetostat r/r fl eha
today mutant wildtyp popul
mutant popul orr ticker
interestingli cr rate tick wild
type popul orr cr rate
constant increment posit epizym
look forward resolut clinic hold path
registr fl reiter buy pt peter lawson
report result wednesday june earn
call et estim pt unchang charl
construct materi base analysi may state-
level construct employ data report morn
underli trend footprint buy-rat name
appear acceler
think look rel attract right stock
disloc ytd vs subsector
underli trend insid footprint tracker rohit
page
sale effort steadi intact reiter buy continu
believ make signific progress drive
fundament busi host two event last week
includ call jeff renzi head global sale peter
altabef ceo total contract valu steadili improv key
area support compani goal achiev posit
revenu growth view inflect posit revenu
growth steadi margin improv judici cash flow
manag set firm success continu work
pension overhang note increas interest
rate aid stori frank atkin
 near-record prefer equiti sale may maintain pt
hold rate model little-chang follow good
result chang guidanc last week nareit
sale million may ampl invest opportun
particularli retail meanwhil interest rate mezzanin
invest appear come bit like sell
rather execut purchas option dividend yield
near-term earn growth high extrem
sensit cap rate assumpt view
rel high-risk stock either direct michael lewi
inc buy confid
improv busi model swell take pt buy
improv busi model host investor meet
ceo tom edman develop greater confid
compani improv busi model includ abil
grow sale expand margin achiev ep
consensu highlight recent
analyst day note increas confid factor might
trigger transit valuat methodolog blend
ev/ebitda price-to-earnings straight price-to-earnings basi confid
swell increas pt base still
semi compon distributor construct
signal consum sentiment momentum proprietari
month lead indic semi industri growth began
neg territori align indic fade
growth cycl view recent macro indic turn
posit today read remain construct retain
balanc sector view highlight top long idea
fading-growth part cycl structur grower
merger/cost reduc
page
june syntel inc synt ndr vice-president financ head ir texa
june t-mobil us inc group lunch head ir new york
june ndr presid ceo cfo kc
june corp ndr chairman ceo svp corp development/strategi director ir boston new
june dowdupont inc dwdp ndr director ir financ manag ir director ir kc mid-west
june actuant corp atu ndr ceo ir chicago
june inc ndr cfo vice-president ir mid-west canada
juli pinnacl west capit corpor group breakfast evp/cfo director ir ir new york new
juli young gunz reits- group dinner- new york new
page
june thor industri inc life fit bc bu tour chicago
june tour hudson yard relat compani vice chairman relat compani svp head sale hudson yard new york new
august strh annual chariti poker tournament enercom denver
august group meet enercom oil ga confer denver co new
novemb lodg game leisur summit- boston
june estimate conf call kol leader
june estimate conf call tetraphas pharmaceut inc ttph new
juli estimate conf call head industri estat
june jennif demba michael young bank mid-atlant
june chappel consum product food beverag mid-west
page
page
issu research report suntrust robinson humphrey inc analyst name report herebi certifi
recommend opinion express accur reflect research analyst person view
subject secur compani discuss herein part research analyst compens directli
indirectli relat specif recommend view express report
